|
B3GALNT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.020200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.299600E-03 |
| Normal-vs-Stage2 |
6.432200E-01 |
| Normal-vs-Stage3 |
3.850600E-01 |
| Normal-vs-Stage4 |
9.033400E-01 |
| Stage1-vs-Stage2 |
5.169200E-01 |
| Stage1-vs-Stage3 |
4.013800E-01 |
| Stage1-vs-Stage4 |
3.937000E-01 |
| Stage2-vs-Stage3 |
9.145800E-01 |
| Stage2-vs-Stage4 |
6.995400E-01 |
| Stage3-vs-Stage4 |
5.572200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.115600E-02 |
| Normal-vs-AfricanAmerican |
3.618400E-01 |
| Normal-vs-Asian |
5.676800E-03 |
| Caucasian-vs-AfricanAmerican |
4.183400E-01 |
| Caucasian-vs-Asian |
5.235600E-02 |
| AfricanAmerican-vs-Asian |
2.373900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.282000E-03 |
| Normal-vs-Female |
6.779000E-01 |
| Male-vs-Female |
5.922700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.051000E-01 |
| Normal-vs-Extreme_Weight |
1.337580E-03 |
| Normal-vs-Obese |
3.318800E-01 |
| Normal-vs-Extreme_Obese |
5.722500E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.246200E-01 |
| Normal_Weight-vs-Obese |
7.233600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.989600E-01 |
| Extreme_Weight-vs-Obese |
7.751800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.094800E-01 |
| Obese-vs-Extreme_Obese |
4.599800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.583000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.258600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.898200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.03289999997536E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.050400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.881800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.966400E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.803900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.011000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.240700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.542400E-02 |
| Normal-VS-Type2 PRCC |
4.441700E-04 |
| Normal-VS-KIRP CIMP |
1.749440E-01 |
| Normal-VS-Unclassified PRCC |
4.188600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.822500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.097990E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.041000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.256110E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.269700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.935800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09800000003268E-06 |
| Normal-vs-N1 |
3.902400E-01 |
| Normal-vs-N2 |
8.589800E-01 |
| N0-vs-N1 |
9.663700E-03 |
| N0-vs-N2 |
2.664800E-01 |
| N1-vs-N2 |
8.221200E-01 |
|
|
